These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16832008)

  • 1. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal vaccination against influenza.
    Weller TH
    N Engl J Med; 2005 Mar; 352(10):1044-6; author reply 1044-6. PubMed ID: 15758019
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
    Manuel O; Humar A; Berutto C; Ely L; Giulieri S; Lien D; Meylan PR; Weinkauf J; Pascual M; Nador R; Aubert JD; Kumar D
    J Heart Lung Transplant; 2011 Jun; 30(6):679-84. PubMed ID: 21377898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
    Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 12. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian influenza serosurvey prior to the 1992-1993 season.
    Can Commun Dis Rep; 1992 Nov; 18(22):161-6. PubMed ID: 1291010
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza and current guidelines for its control.
    Gall SA
    Infect Dis Obstet Gynecol; 2001; 9(4):193-5. PubMed ID: 11916174
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranasal versus injectable influenza vaccine.
    Genton B; D'Acremont V
    Clin Infect Dis; 2004 Sep; 39(5):754; author reply 754-5. PubMed ID: 15356796
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza vaccine 2007-2008.
    Med Lett Drugs Ther; 2007 Oct; 49(1271):81-3. PubMed ID: 17912142
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.